Constitutive upregulation of transcription factors underlies permissive bradyzoite differentiation in a natural isolate of <i>Toxoplasma gondii</i>

<i>Toxoplasma gondii</i> is a widespread protozoan that chronically infects ~30% of the world's population. <i>T. gondii</i> can differentiate between the fast-growing life stage that causes acute infection and the slow-growing stage that persists in the host for extended periods of time. The slow-growing stage cannot be eliminated by the host immune response or currently known antiparasitic drugs. Studies on the slow-growing stage have been limited due to the limitations of <i>in vivo</i> experiments and the challenges of <i>in vitro</i> manipulation. Here, we characterize a natural isolate of <i>T. gondii</i>, which constitutively expresses factors that drive development and that is permissive to convert to the slow-growing stage under stress conditions <i>in vitro</i>. The strain presents a novel <i>in vitro</i> model for studying the chronic phase of toxoplasmosis and identifying new therapeutic treatments for chronic infections.

Authors

Institutions

Publication Details

Journal
mBio
Published
2024-08-16
DOI
https://doi.org/10.1128/mbio.00641-24
Citations
6
Primary Topic
Toxoplasma gondii Research Studies
Type
article
Field-Weighted Citation Impact
3.09

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Constitutive upregulation of transcription factors underlies permissive bradyzoite differentiation in a natural isolate of Toxoplasma gondii

Wanyi Huang, L. David Sibley, Jing Xia, Taher Uddin et al.
6 citations
mBio
Toxoplasma gondii Research Studies
3.09
article

Constitutive upregulation of transcription factors underlies permissive bradyzoite differentiation in a natural isolate of Toxoplasma gondii

Wanyi Huang, L. David Sibley, Jing Xia, Taher Uddin, Yong Fu
article en
6 citations

Abstract

<i>Toxoplasma gondii</i> is a widespread protozoan that chronically infects ~30% of the world's population. <i>T. gondii</i> can differentiate between the fast-growing life stage that causes acute infection and the slow-growing stage that persists in the host for extended periods of time. The slow-growing stage cannot be eliminated by the host immune response or currently known antiparasitic drugs. Studies on the slow-growing stage have been limited due to the limitations of <i>in vivo</i> experiments and the challenges of <i>in vitro</i> manipulation. Here, we characterize a natural isolate of <i>T. gondii</i>, which constitutively expresses factors that drive development and that is permissive to convert to the slow-growing stage under stress conditions <i>in vitro</i>. The strain presents a novel <i>in vitro</i> model for studying the chronic phase of toxoplasmosis and identifying new therapeutic treatments for chronic infections.

mBioVol. 15(9)
Washington University in St. Louis (US)
National Institutes of Health
Good health and well-being
Openalex Percentile: Top 8%
Toxoplasma gondii Research Studies
3.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.